Relmada Therapeutics, Inc. announced that Dr. Raj S. Pruthi’s employment as Chief Medical Officer – Urology ended on September 3, 2026. Relmada Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for urological diseases.
